MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
This 5 days course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.
WHAT WILL YOU GAIN?: Definitions and methods in Pharmacovigilance together with the regulatory aspects, followed by practical examples. Knowledge in the diagnosis of adverse drug reactions, signal detection and signal management, modern technologies and social media, risk management.